Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Roberta Cap"'
Autor:
Simone Scagnoli, Simona Pisegna, Angela Toss, Roberta Caputo, Michelino De Laurentiis, Michela Palleschi, Ugo de Giorgi, Enrico Cortesi, Agnese Fabbri, Alessandra Fabi, Ida Paris, Armando Orlandi, Giuseppe Curigliano, Carmen Criscitiello, Ornella Garrone, Gianluca Tomasello, Giuliana D’Auria, Patrizia Vici, Enrico Ricevuto, Federica Domati, Claudia Piombino, Sara Parola, Roberta Scafetta, Alessio Cirillo, Beatrice Taurelli Salimbeni, Francesca Sofia Di Lisa, Lidia Strigari, Robert Preissner, Maurizio Simmaco, Daniele Santini, Paolo Marchetti, Andrea Botticelli
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-10 (2024)
Abstract Abemaciclib demonstrated clinical benefit in women affected by HR+/HER2− advanced breast cancer (aBC). Drug-drug interactions (DDIs) can lead to reduced treatment efficacy or increased toxicity. This retro-prospective study aimed to evalua
Externí odkaz:
https://doaj.org/article/9f47555ab4e54af1bfb2ac3aefc63ec9
Autor:
Federica Miglietta, Letizia Pontolillo, Carmine De Angelis, Roberta Caputo, Monica Marino, Emilio Bria, Rossana Di Rienzo, Annarita Verrazzo, Carlo Buonerba, Giampaolo Tortora, Giuseppe Di Lorenzo, Lucia Del Mastro, Mario Giuliano, Filippo Montemurro, Fabio Puglisi, Valentina Guarneri, Michelino De Laurentiis, Luca Scafuri, Grazia Arpino
Publikováno v:
Breast, Vol 75, Iss , Pp 103713- (2024)
Background: The last years have seen unprecedented improvement in breast cancer (BC) survival rates. However, this entirely apply to female BC patients, since gender minorities (male, transgender/gender-diverse) are neglected in BC phase III registra
Externí odkaz:
https://doaj.org/article/ecffa4c0932d4de3b840fb79430d4ff5
Autor:
Veronica Tisato, Juliana A. Silva, Fabio Scarpellini, Roberta Capucci, Roberto Marci, Ines Gallo, Francesca Salvatori, Elisabetta D’Aversa, Paola Secchiero, Maria L. Serino, Giorgio Zauli, Ajay V. Singh, Donato Gemmati
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Spontaneous abortion is a pregnancy complication characterized by complex and multifactorial etiology. About 5% of childbearing women are globally affected by early pregnancy loss (EPL) and most of them experience recurrence (RPL). Epigeneti
Externí odkaz:
https://doaj.org/article/75b58436cab84529ae29a1d613d4f356
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-18 (2024)
Abstract Lithium-ion batteries (LIBs) have become an essential technology for the green economy transition, as they are widely used in portable electronics, electric vehicles, and renewable energy systems. The solid-electrolyte interphase (SEI) is a
Externí odkaz:
https://doaj.org/article/88ec0a9a5e1a4e2fb9aa850bd310d7a6
Autor:
Anna Crispo, Livia S. A. Augustin, Assunta Luongo, Claudia Calderaio, Joao Breda, Sergio Coluccia, Alessandra Calabrese, Vittorio Marrazzo, Rosa Giannatiempo, Paola Trasacco, Elvira Palumbo, Sara Vitale, Giuseppe Porciello, Piergiacomo Di Gennaro, Roberta Caputo, Giuseppe Buono, Claudio Vernieri, Francesco Schettini, Maria Grimaldi, Flavia Nocerino, Egidio Celentano, Alfonso Amore, Mario Giuliano, Pietro De Placido, Carmine De Angelis, Roberto Bianco, Michelino De Laurentiis, Carlo La Vecchia, Grazia Arpino
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Obesity and metabolic disorders have been associated with poor outcomes in non-Mediterranean breast cancer (BC) patients. The purpose of this study was to investigate the prognostic potential of anthropometric variables in patients with earl
Externí odkaz:
https://doaj.org/article/f3a2ca9b48954ebe9d773daeec362742
Autor:
Roberta Capello, Camilla Lenzi
Publikováno v:
npj Urban Sustainability, Vol 3, Iss 1, Pp 1-7 (2023)
Abstract This paper reassesses the displacement effects of automation technologies from an urban perspective by highlighting heterogeneous effects in urban vs non-urban settings. Specifically, the paper argues that automation technologies in the form
Externí odkaz:
https://doaj.org/article/606b31582dc64cbe887625b26ebe1cc5
Autor:
Roberta Caputo, Giuseppe Buono, Michela Piezzo, Claudia Martinelli, Daniela Cianniello, Alessandro Rizzo, Francesco Pantano, Nicoletta Staropoli, Rodolfo Cangiano, Salvatore Turano, Ida Paris, Francesco Nuzzo, Alessandra Fabi, Michelino De Laurentiis
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveThe objective of this multicenter, observational, retrospective analysis was to evaluate the safety and efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer (mTNBC) patients managed according to common clinical pract
Externí odkaz:
https://doaj.org/article/459d82770c6e4daf8ad600efc6033c0e
Autor:
Simone Scagnoli, Simona Pisegna, Angela Toss, Roberta Caputo, Michelino De Laurentiis, Michela Palleschi, Ugo de Giorgi, Enrico Cortesi, Agnese Fabbri, Alessandra Fabi, Ida Paris, Armando Orlandi, Giuseppe Curigliano, Carmen Criscitiello, Ornella Garrone, Gianluca Tomasello, Giuliana D’Auria, Patrizia Vici, Enrico Ricevuto, Federica Domati, Claudia Piombino, Sara Parola, Roberta Scafetta, Alessio Cirillo, Beatrice Taurelli Salimbeni, Francesca Sofia Di Lisa, Lidia Strigari, Robert Preissner, Maurizio Simmaco, Daniele Santini, Paolo Marchetti, Andrea Botticelli
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/16a6bc6a49b04c55b1e7f75ad7375e59
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
While standard treatment has shown efficacy in patients with breast cancer gene (BRCA) mutations, recurrence rates are high and additional effective therapies are needed. Olaparib, a poly adenosine diphosphate–ribose polymerase (PARP) inhibitor, ap
Externí odkaz:
https://doaj.org/article/61bf64af47064da6b31404b3bfb811ad
Autor:
Andrea D’Arienzo, Annarita Verrazzo, Martina Pagliuca, Fabiana Napolitano, Sara Parola, Martina Viggiani, Roberta Caputo, Fabio Puglisi, Mario Giuliano, Lucia Del Mastro, Grazia Arpino, Michelino De Laurentiis, Filippo Montemurro
Publikováno v:
EClinicalMedicine, Vol 62, Iss , Pp 102113- (2023)
Summary: Antibody–drug conjugates (ADCs) represent a novel and evolving class of antineoplastic agents, constituted by monoclonal antibody linked to biologically active drugs, delivering cytotoxic compounds at the tumor site, reducing the likelihoo
Externí odkaz:
https://doaj.org/article/ff3dcb28efa749fa9f8f660c9f545b5d